ANIP logo

ANIP

ANI Pharmaceuticals Inc.

$93.50
+$0.97(+1.05%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$1.99B
Volume
283.24K
52W Range
$52.50 - $93.72
Target Price
$95.50
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$76.3M$128.6M$176.8M$201.6M$206.5M$208.5M$216.1M$316.4M$486.8M$614.4M
Total Revenue
$76.3M$128.6M$176.8M$201.6M$206.5M$208.5M$216.1M$316.4M$486.8M$614.4M
COST OF GOODS SOLD
Cost of Revenue
$12.7M$48.8M$79.0M$73.0M$63.2M$87.2M$100.6M$138.8M$241.3M$317.9M
GROSS PROFIT
Gross Profit
$63.6M$79.8M$97.8M$128.6M$143.4M$121.3M$115.5M$177.6M$245.5M$296.4M
OPERATING EXPENSES
Operating Expenses
$30.9M$53.1M$68.6M$93.2M$127.0M$114.4M$143.7M$204.0M$194.7M$305.1M
Research & Development
$2.9M$2.9M$9.1M$15.4M$19.8M$16.0M$11.4M$22.3M$34.3M$44.6M
Research Expense
----------$16.0M$11.4M$22.3M$34.3M$44.6M
Selling, General & Administrative
$21.2M$27.8M$31.6M$44.1M$55.8M$65.0M$84.3M$124.0M$161.7M$249.6M
Selling & Marketing Expenses
----------$65.0M$84.3M$124.0M$161.7M$249.6M
Depreciation & Amortization
$6.9M$22.3M$27.9M$33.7M$44.6M$44.6M$47.3M$57.0M----
Depreciation & Amortization
$6.9M$22.3M$27.9M$33.7M$44.6M$44.6M$47.3M$57.0M----
Amortization
----------$44.6M--------
Other Operating Expenses
--------$6.7M$-11.3M$780.0K$670.0K$-1.3M$10.9M
OPERATING INCOME
Operating income
$32.7M$26.8M$29.2M$35.4M$16.4M$7.0M$-28.2M$-26.4M$50.8M$-8.7M
EBITDA
$39.6M$42.3M$56.3M$68.6M$60.7M$28.1M$3.1M$23.7M$110.5M$80.4M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$11.0M$11.3M$12.0M$14.8M$13.0M$9.5M$11.9M$28.1M$26.9M$17.6M
Net Non-Operating Interest Income/Expense
$11.0M$11.3M$12.0M$14.8M$13.0M$9.5M$11.9M$-28.1M$-26.9M$-17.6M
Other Income/Expense
$41.0K$-6.8M$-848.0K$-550.0K$-303.0K$-940.0K$-16.0M$3.9M$-1.1M$-7.7M
Other Special Charges
----------$-11.8M$-4.3M$670.0K$1.1M$3.7M
SPECIAL ITEMS
Restructring And Mn A Income
------------$500.0K$5.7M$1.1M--
Special Income Charges
--$6.7M$903.0K--$75.0K$446.0K$11.6M$-5.7M$-1.1M--
Impairment of Capital Assets
--$6.7M$903.0K--$75.0K$446.0K$2.4M------
PRE-TAX INCOME
EBIT
$32.7M$20.0M$28.4M$34.8M$16.1M$-16.5M$-44.1M$-36.0M$50.8M$-920.0K
Pre-Tax Income
$21.7M$8.7M$16.3M$20.1M$3.2M$-26.0M$-56.1M$-64.0M$23.8M$-18.5M
INCOME TAX
Tax Provision
$6.4M$4.7M$17.4M$4.6M$-2.9M$-3.4M$-13.5M$14.8M----
NET INCOME
Net Income
$15.4M$3.9M$-1.1M$15.5M$6.1M$-22.5M$-42.6M$-80.4M$23.8M$-18.5M
Net Income (Continuing Operations)
$15.4M$3.9M$-1.1M$15.5M$6.1M$-22.5M$-42.6M$-78.8M$23.8M$-18.5M
Net Income (Discontinued Operations)
$15.4M$3.9M$-1.1M$15.5M$6.1M$-22.5M$-42.6M$-80.4M$23.8M$-18.5M
Net Income (Common Stockholders)
$15.3M$3.9M$-1.1M$15.3M$6.0M$-22.5M$-42.8M$-80.4M$22.2M$-20.1M
Normalized Income
$16.0M$13.1M$12.9M$14.7M$295.0K$-28.9M$-57.9M$-41.3M$18.6M$-16.1M
TOTALS
Total Expenses
$-43.6M$-101.9M$-147.6M$-166.2M$-190.1M$-201.5M$-244.3M--$436.0M$623.0M
SHARE & EPS DATA
Average Shares Outstanding
$11.4M$11.4M$11.5M$11.7M$11.8M$12.0M$12.6M$16.3M$18.0M$19.3M
Average Shares Outstanding (Diluted)
$11.6M$11.6M$11.5M$11.8M$12.0M$12.0M$12.6M$16.3M$18.2M$19.3M
Shares Outstanding
$11.5M$11.6M$11.7M$11.9M$12.1M$12.3M$16.7M$12.7M$21.7M$21.7M
Basic EPS
$1.34$0.34$-0.09$1.31$0.51$-1.88$-3.4$-3.05$0.86$-1.04
Basic EPS (Continuing Operations)
$1.34$0.34$-0.09$1.31$0.51$-1.88$-3.4$-3.05$0.86$-1.04
Diluted EPS
$1.32$0.34$-0.09$1.3$0.50$-1.88$-3.4$-3.05$0.85$-1.04
Diluted EPS (Continuing Operations)
$1.32$0.34$-0.09$1.3$0.50$-1.88$-3.4$-3.05$0.85$-1.04
Dividend Per Share
------------$7.6------
OTHER METRICS
Accrued Preferred Stock Dividends
------------$190.0K----$1.6M
Gain On Sale Of P P E
------------------$5.3M
Minority Interests
--------------$-1.6M----
Other Costof Revenue
--------------$138.8M$181.5M$250.2M
Other Impairment Of Capital Assets
----------$446.0K$2.4M$112.0K$112.0K$7.6M
Otherunder Preferred Stock Dividend
------------$190.0K$1.6M$1.6M$1.6M
Preferred Stock Dividends
------------$190.0K$1.6M$1.6M$1.6M
Othspecchg
------------$8.8M------
Restruct
------------$500.0K$5.7M$1.1M--

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ANIP$93.50+1.0%283.24K
3
4
5
6

Get ANI Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.